AXDX - צמיחת הכנסות משנה לשנה ב-12 החודשים האחרונים Accelerate Diagnostics Inc

Comparable year-over-year sales growth over 12 months demonstrates the effect of implementing hospital rapid diagnostic systems, which create sustainable B2B dependency. Revenues are based on the sale of equipment and consumable cartridges. Despite its leadership in sepsis detection, expansion requires significant investment. The value of -8.40 reflects the latest metric value, allowing for an assessment of the real dynamics of Accelerate Diagnostics (AXDX) operational inflows.

This indicator calculates the percentage change in total revenue over the last twelve months relative to the same period last year, neutralizing seasonal fluctuations and revealing the true vector of business expansion. For Accelerate Diagnostics (AXDX), the TTM revenue growth trajectory compared to last year confirms the monetization of high laboratory confidence in the accuracy of its diagnostic systems, transforming the brand's reputational stability into real financial scale.